We are pleased to announce that Bottneuro has entered into a technology partnership with Samsung to support its innovative approach to treating Alzheimer's disease. The partnership will involve the use of a Samsung Galaxy Tab S8+ Enterprise Edition Tablet, which will allow for at-home treatment and monitoring through integrated EEG functionality.

Through this collaborative effort, the development of the solution will be further advanced. Samsung has been providing local experts to support Bottneuro since its founding in 2021. Bottneuro will benefit from Samsung's Knox Suite solution, which includes products such as Knox Manage, E-FOTA, KAI, KSP, and Knox Configure for easy and automated device pre-configuration.

The partnership with Samsung represents a significant milestone for Bottneuro, as it will help the company to expand its reach and deliver innovative therapies to patients with Alzheimer's disease. With the Miamind® Neurostimulator and Samsung Galaxy Tab S8+ Enterprise Edition Tablet, patients can now receive treatment in the comfort of their own homes, and doctors can monitor their progress more closely through the integrated EEG functionality.

Read full Article here